Section Review: Cardiovascular & Renal: Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors
- 1 November 1996
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 6 (11) , 1147-1164
- https://doi.org/10.1517/13543776.6.11.1147
Abstract
The development of single molecules which possess the ability to inhibit both of the membrane-bound zinc metalloproteases, angiotensin-converting enzyme EC 2.4.15.1 (ACE) and neutral endopeptidase EC 3.4.24.11 (NEP), has been the focus of much recent drug discovery effort. These agents represent a new class of cardiovascular agent that should be more effective in treating a broader range of hypertensive patient and in congestive heart failure (CHF). Dual ACE and NEP inhibitors are currently under clinical investigation for hypertension and CHF and several more are under preclinical study. This review focuses on ACE/NEP dual inhibitors reported in the patent and primary literature over the past four years.Keywords
This publication has 15 references indexed in Scilit:
- Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidasePublished by Elsevier ,2003
- Optimal Recognition of Neutral Endopeptidase and Angiotensin-Converting Enzyme Active Sites by Mercaptoacyldipeptides as a Means To Design Potent Dual InhibitorsJournal of Medicinal Chemistry, 1996
- Design of Orally Active Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme with Long Duration of ActionJournal of Medicinal Chemistry, 1996
- Mercaptoacyl Dipeptides as Orally Active Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral EndopeptidaseJournal of Medicinal Chemistry, 1996
- Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with HypertensionJournal of Cardiovascular Pharmacology, 1995
- Synthesis of benzo-fused, 7,5- and 7,6-fused azepinones as conformationally restricted dipeptide mimeticsTetrahedron Letters, 1995
- High performance liquid chromatography/ionspray mass spectrometry of N‐ethylmaleimide and acrylic acid ester derivatives for bioanalysis of thiol compoundsRapid Communications in Mass Spectrometry, 1994
- 30 Systemic and regional haemodynamic effects of a novel mixed angiotensin I converting enzyme and neutral endopeptidase inhibitor, alatrioprilat, in anaesthetized dogsJournal Of Hypertension, 1993
- Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11Biochemical Journal, 1993
- Mechanisms of atrial natriuretic factor-induced vasodilationPharmacology & Therapeutics, 1990